Patient-Derived Organoids for Rectal Cancer

Not Applicable

Completed

• Conditions: Rectum Cancer
• Interventions: Other: Biopsy

• Registration Number: NCT04371198
• Lead Sponsor: Duke University

Brief Summary

The purpose of this study is to determine the feasibility of establishing patient-derived organoids from pre-treatment rectal adenocarcinoma biopsies.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-04-29
• Study First Submitted QC: 2020-04-29
• Study First Posted: 2020-05-01
• Study Start: 2020-09-18
• Primary Completion: 2022-08-17
• Study Completion: 2022-08-17
• Status Verified: 2022-10
• Results First Submitted: 2022-10-11
• Results First Submitted QC: 2022-10-11
• Last Update Submitted: 2022-10-11
• Results First Posted: 2023-08-28
• Last Update Posted: 2023-08-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Organoid	Biopsy	-

Primary Outcome Measures

Name	Time	Method
Number of Participants With Biopsies That Form Spherical Organoids	Baseline

Trial Locations

Locations (1)

Duke Cancer Center; 🇺🇸 Durham, North Carolina, United States